Episode 8: Startup Science Spotlight – BioAesthetics

Join host James Zanewicz, CBO of Tulane University School of Medicine, as he hosts the podcast’s first “Startup Science Spotlight” with Dr. Nick Pashos, founder and CEO of BioAesthetics. Learn about how the company got its start and its technological innovations around cell-free graft applications – as well as how you can get in on the current investment round.

Episode 8: Startup Science Spotlight – BioAesthetics

Episode 7: Bio on the Bayou

Join hosts James Zanewicz (Tulane University School of Medicine) and Patrick Reed (LSU Health New Orleans) as they discuss the success of BIO on the BAYOU, the annual Gulf South biotech showcase – and get a peek into the upcoming 2023 program.

Episode 6: Drug Development and Reimbursement

Join host Patrick Reed, with LSU Health New Orleans to welcome special guest, Allyson Best, Director of Technology Commercialization at the University of Mississippi for a discussion on drug development and reimbursement. Her team manages innovations of UM and her primary role is on the tech transfer/out-licensing side of biotech. She also teaches a graduate course at the university focusing on biomedical development, regulation, and marketing.

Episode 5: Executive in Residence 6-Month Update

Join Frequent guest Dr. Elaine Hamm as she provides updates on her “executive in residence” role at the Tulane School of Medicine, and how it has evolved over the first six months. Elaine also discusses some of the amazing science and opportunities she has discovered at Tulane.

Episode 4: “Executive in Residence” in Academia

Podcast: BIO from the BAYOU

Episode 4: ”Executive in Residence” in Academia (Elaine Hamm, Ascend BioVentures)

Tune in for this episode of the BIO from the BAYOU podcast, featuring stories and industry insights from the experts who can provide frontline access to this unique ecosystem. Host James Zanewicz, with Tulane University’s School of Medicine, welcomes back special guest Dr. Elaine Hamm. Elaine has served in countless roles industry wide; today she occupies the position of being the first “Executive in Residence” at Tulane University School of Medicine, and together they explore what this role means.

With a lot of perspective and experience in this area, Elaine shares some of the biggest challenges she seesfor academic scientists who are trying to engage with the business world. She describes the basic and boring scientific research questions needed for commercial activity, in contrast to the more complex and “fun” academic experiments. While figuring out product manufacturing can be quite boring, Elaine shares that this often proves to be one of the main killers for companies.

James asks Elaine to discuss what made her decide to venture back into the academy – and she shares her love for “boring” experiments and why the role of COO was one of her favorites (as it is necessary for there to be someone who simply helps others check the boxes). But how else can the role of being an Executive in Residence add value to the field? Since these experts are often those who have, “been there and done that”, they offer a great perspective gained through their various personal life lessons.

Shifting topics, these two chat about partnering strategies for academics and companies. Elaine cannot overemphasize enough the need to do your basic diligence about what science people will need to see. It’s important to make it as easy as possible to make someone want to partner with you. By focusing on the science, rather than the market, you can better show what differentiates you from others and where your data ultimately rests.

Learn about Elaine’s plan to hold “Lunch and Learns” and why she wants to begin with the Micro-immuno field. Conducting these meetings around what the industry cares about will help equip leaders in developing new vaccines, knowing what models to follow, and what corporate higher-ups want to see for eventual drug development and approvals. Elaine has insights for those who are passionate about impact in order to have success moving product forward. Understanding what it will take from a data perspective to get something approved is invaluable!

Transitioning topics, Elaine talks about how EIR can be done virtually and the advancements that have become capable with technology. Having previously filled two separate roles at a University (Scientist and Tech Transfer professional), Elaine shares advice for those following in her footsteps: such as the importance of keeping up with documents, and being hyper-focused on the data and experiments that truly matter.

As the conversation draws to a close, James asks Elaine to touch on how universities and small companies can best approach partnering, even if they are not located within one of the major biotech hubs. She says it is simple: What can these universities or companies do to make it worthwhile for her to have a relationship?She talks about finding the avenue for someone to truly be of help, along with what can be done to make it a flexible and advantageous role.

Thanks for tuning in. As we learn more from new experts, we will share more. Please don’t forget to like, share, and subscribe!

Links:

Learn more about Elaine Hamm, Ascend BioVentures and connect on LinkedIn.

Connect with Patrick Reed and learn about LSU Health New Orleans.

Connect with James Zanewicz and learn about Tulane University (and its School of Medicine).

Learn more about BIO from the BAYOU – the show, the upcoming event, and more!

Learn more about our podcast sponsor, The XLerator Network.

Episode 3: Building Biotech Outside the Major Clusters

Podcast: BIO from the BAYOU

Episode 3: Building Biotech Outside the Major Clusters (Elaine Hamm, Ascend BioVentures)

Join us for this episode of BIO from the BAYOU, a podcast where we feature stories and industry insights from the experts located in and working with the bustling biotech scene of the Gulf South Region’s vibrant ecosystem. New Orleans is the place where people come for the science and stay for the food, festivals, and resilient culture. Join host James Zanewicz, with Tulane University’s School of Medicine to welcome special guest, Dr. Elaine Hamm. Elaine’s countless roles in industry have provided a great foundation for this conversation on how to build a biotech company when you are not located in one of the major biotech clusters.

The conversation kicks off with Elaine’s explanation of what made her want to run Biotech companies in the first place. When it comes to life sciences, people think of the major clusters and Elaine shares her first-hand experience of how the virtual world that she was already operating in herself, and the pandemic ushered in for the entire industry, is altering the landscape. After examining some of the barriers to being outside these clusters, Elaine shares some benefits -including the ability to find seed funding, accessibility of capital, lessened competition, and greater masses of people who are readily willing to assist with resources.

Shifting the conversation, James asks Elaine to discuss what programs have proved to be beneficial for her, and how she was able to access them. You’ll directly learn about the federal programs and tools that can complete – and pay for – studies for you as examine drug safety and toxicity! They then discuss how she approaches any additional fundraising. While it often depends on the company, Elaine chats about how foundations are great avenues to find a lot of passionate people and resources that are specific to various diseases.

Learn how Elaine has made the role of “Virtual CEO” work. She shares the importance of getting good at product management, outsourcing, and how she identifies the best partners for their products. Through interviewing and the key desire for constant communication, she describes experiences in testing the waters before plunging into a full partnership.